PortfoliosLab logoPortfoliosLab logo
NWBO vs. ROOT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NWBO vs. ROOT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Northwest Biotherapeutics, Inc. (NWBO) and Root, Inc. (ROOT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NWBO achieves a -16.85% return, which is significantly higher than ROOT's -27.76% return.


NWBO

1D
-0.83%
1M
-18.51%
YTD
-16.85%
6M
-23.86%
1Y
-26.28%
3Y*
-31.62%
5Y*
-33.92%
10Y*
-11.32%

ROOT

1D
2.17%
1M
-9.06%
YTD
-27.76%
6M
-28.65%
1Y
-60.23%
3Y*
68.13%
5Y*
-23.35%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

NWBO vs. ROOT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
NWBO
Northwest Biotherapeutics, Inc.
-16.85%-16.74%-60.81%-10.64%12.07%-54.10%34.96%
ROOT
Root, Inc.
-27.76%-0.50%592.65%133.41%-91.95%-80.27%-39.58%

Correlation

The correlation between NWBO and ROOT is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.05

Correlation (5Y)
Calculated over the trailing 5-year period

0.07

Correlation (All Time)
Calculated using the full available price history since Oct 28, 2020

0.07

Fundamentals

EPS

NWBO:

-$0.06

ROOT:

$3.35

PS Ratio

NWBO:

297.41

ROOT:

0.56

Total Revenue (TTM)

NWBO:

$937.00K

ROOT:

$1.56B

Gross Profit (TTM)

NWBO:

$416.00K

ROOT:

$279.50M

EBITDA (TTM)

NWBO:

-$79.62M

ROOT:

$88.80M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NWBO vs. ROOT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NWBO
NWBO Risk / Return Rank: 2323
Overall Rank
NWBO Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
NWBO Sortino Ratio Rank: 2727
Sortino Ratio Rank
NWBO Omega Ratio Rank: 2727
Omega Ratio Rank
NWBO Calmar Ratio Rank: 1919
Calmar Ratio Rank
NWBO Martin Ratio Rank: 1818
Martin Ratio Rank

ROOT
ROOT Risk / Return Rank: 99
Overall Rank
ROOT Sharpe Ratio Rank: 88
Sharpe Ratio Rank
ROOT Sortino Ratio Rank: 88
Sortino Ratio Rank
ROOT Omega Ratio Rank: 99
Omega Ratio Rank
ROOT Calmar Ratio Rank: 77
Calmar Ratio Rank
ROOT Martin Ratio Rank: 1212
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NWBO vs. ROOT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Northwest Biotherapeutics, Inc. (NWBO) and Root, Inc. (ROOT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NWBOROOTDifference
Sharpe ratioReturn per unit of total volatility

+0.49

Sortino ratioReturn per unit of downside risk

+1.09

Omega ratioGain probability vs. loss probability

0.98

0.84

+0.13

Calmar ratioReturn relative to maximum drawdown

-0.63

-0.89

+0.26

Martin ratioReturn relative to average drawdown

-1.12

-1.29

+0.17

NWBO vs. ROOT - Sharpe Ratio Comparison

The current NWBO Sharpe Ratio is -0.39, which is higher than the ROOT Sharpe Ratio of -0.88. The chart below compares the historical Sharpe Ratios of NWBO and ROOT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NWBO vs. ROOT - Drawdown Comparison

The maximum NWBO drawdown since its inception was -99.99%, roughly equal to the maximum ROOT drawdown of -99.29%. Use the drawdown chart below to compare losses from any high point for NWBO and ROOT.


Loading charts...

Drawdown Indicators


NWBOROOTDifference

Max Drawdown

Largest peak-to-trough decline

-99.99%

-99.29%

-0.70%

Max Drawdown (1Y)

Largest decline over 1 year

-41.54%

-67.76%

+26.22%

Max Drawdown (3Y)

Largest decline over 3 years

-82.16%

-75.68%

-6.48%

Max Drawdown (5Y)

Largest decline over 5 years

-90.29%

-98.26%

+7.97%

Max Drawdown (10Y)

Largest decline over 10 years

-91.93%

Current Drawdown

Current decline from peak

-99.99%

-89.26%

-10.73%

Average Drawdown

Average peak-to-trough decline

-97.15%

-83.76%

-13.39%

Ulcer Index

Depth and duration of drawdowns from previous peaks

23.56%

46.77%

-23.21%

Volatility

NWBO vs. ROOT - Volatility Comparison

The current volatility for Northwest Biotherapeutics, Inc. (NWBO) is 17.80%, while Root, Inc. (ROOT) has a volatility of 24.39%. This indicates that NWBO experiences smaller price fluctuations and is considered to be less risky than ROOT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NWBOROOTDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.80%

24.39%

-6.59%

Volatility (6M)

Calculated over the trailing 6-month period

47.20%

46.29%

+0.91%

Volatility (1Y)

Calculated over the trailing 1-year period

67.36%

68.92%

-1.56%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

81.98%

101.75%

-19.77%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

92.88%

100.07%

-7.19%

Dividends

NWBO vs. ROOT - Dividend Comparison

Neither NWBO nor ROOT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

NWBO vs. ROOT - Financials Comparison

This section allows you to compare key financial metrics between Northwest Biotherapeutics, Inc. and Root, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M20222023202420252026
200.00K
393.50M
(NWBO) Total Revenue
(ROOT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


NWBO and ROOT have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ROOT has higher volatility (24.39%) compared to NWBO (17.80%). In terms of maximum drawdown, NWBO dropped -99.99% vs ROOT's -99.29%.

NWBO currently has the higher Sharpe Ratio (-0.39 vs -0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NWBO and ROOT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer